GeoMx™ Digital Spatial Profiler (DSP)

Bruker’s GeoMx™ Digital Spatial Profiler (DSP) is an advanced platform for multi-omic spatial analysis that enables simultaneous quantification of RNA and proteins in tissue sections, preserving tissue architecture. GeoMx DSP combines fluorescent imaging with photo-cleavable oligonucleotide barcodes, offering digitally quantified molecular profiles in defined regions of interest (ROI).

This technology supports FFPE and fresh frozen (FF) samples, and allows the selection of specific tissue areas to obtain expression data with spatial resolution, through an automated and scalable workflow that integrates with standard histological staining techniques. GeoMx DSP offers a high level of multiplexing: from targeted panels to whole transcriptome via NGS, along with over 1,200 validated proteins, providing a comprehensive view of the tissue microenvironment.

With GeoMx DSP, researchers can map the spatial distribution of biomarkers, explore cellular interactions, and characterize complex biological processes in their native context. It is ideal for studies in oncology, immunology, neuroscience, and drug development, facilitating biomarker discovery and a deep understanding of spatial biology.

Key Features

High sensitivity: 5-log dynamic range and digital readout for quantitative detection of low-expression targets.
Multi-omic assay: the only platform enabling the integration of whole transcriptome and high-plex protein assays (+1,200). Does not damage tissue.
Unmatched protein plexity: the largest antibody-based spatial proteomic assay (+1,200), an order of magnitude higher than any other.
Flexible resolution: segmentation and enrichment of RNA/protein information from discrete or rare cell populations. Proven protein detection.
High throughput: rapid collection of RNA/protein information, compared to cyclic imaging systems, for downstream readout by NGS or nCounter.
Cost-effective: hypothesis-driven and region-of-interest-directed analysis, investing time and resources only in structures and cells of interest.

How does it work?

Whole slides are stained with assay probes and up to four fluorescent markers (morphology markers), and subsequently imaged on the instrument. Guided by the morphology markers, the regions of interest (ROI) of the tissue to be profiled are chosen, and by using masks (areas of illumination, AOI), two or more tissue compartments or cell types within each ROI can optionally be profiled. RNA and protein expression levels are quantified by direct digital counting of barcodes using the nCounter® system or by sequencing on an Illumina platform. Data is analyzed using the open-source DSP Data Analysis (DSPDA) suite.

GeoMx DSP Workflow

DSP probes are labeled with unique oligonucleotide barcodes that are released upon UV light exposure, without damaging the tissue.

GeoMx Probes and Barcodes

Tissue samples are stained with imaging probes (morphology markers) and fluorophore-labeled assay probes using a standard histological workflow.

Regions of interest (ROIs) and areas of illumination (AOIs) are selected on the tissue for interrogation. The tissue is exposed to UV light, and the barcodes are released and subsequently quantified.

Selection of ROIs and AOIs

Unbiased spatial expression is obtained from each tissue mask, with the sensitivity to detect low, medium, and high expressors.

Applications

Discovery of predictive biomarkers for therapeutic response. Tumor microenvironment profiling. Identification of drug mechanisms of action. Revelation of molecular subtypes. Understanding disease mechanisms and progression. Study of preclinical models.
Spatial expression and profiling

Available panels:

Flexible options to meet your research needs. For more information, click on the corresponding icon:

GeoMx DSP RNA Assays

GeoMx DSP Protein Assays

GeoMx DSP Custom Assays

Area:

Multiomics, Omics, Proteomics, Transcriptomics

Technology:

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

NimoTest® Fetal RHD qPCR kit

NIMoTest® Fetal RHD qPCR kit is a kit for determining the fetal RHD genotype from maternal plasma. It is intended for the monitoring of RhD-negative pregnant women to guide anti-RhD immunoprophylaxis and adapt the monitoring of immunised women. Detailed description The kit is designed for duplex quantitative PCR (pPCR) amplification of exons 5 and 7…
BeDia Genomics
Real Time PCR (qPCR)

Genvinset® MTHFR multiplex

In vitro diagnostic kit based on real-time PCR for the simultaneous detection of the A1298C and C677T polymorphisms in the MTHFR gene. Detailed description Operating principle The assay is based on real-time PCR (Real-Time PCR) amplification using TaqMan® hydrolysis probes. Two primer pairs are used to amplify specific regions of the MTHFR gene containing the…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)

Genvinset® FIIFV multiplex

In vitro diagnostic kit for the simultaneous detection of the G20210A mutation in the prothrombin gene (FII) and the G1691A mutation in Factor V using real-time PCR. Detailed description Operating principle The assay is based on the real-time PCR (Real-Time PCR) amplification of specific regions of the FII and FV factor genes containing the mutations…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)

Genvinset® PAI-1/FXIII multiplex

In vitro diagnostic kit based on real-time PCR for the simultaneous detection of the -675 PAI-1 4G/5G polymorphism in the SERPINE1 gene and rs5985 (Val34Leu) in the F13A1 gene, associated with the risk of thrombosis. Detailed description Operating principle Genvinset® PAI-1/FXIII multiplex uses real-time PCR technology (Real-Time PCR) with TaqMan® hydrolysis probes for the qualitative…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)